Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CSRP2 pseudogene 2 (CSRP2P2) is classified as a pseudogene, meaning it resembles a gene (in this case, CSRP2) but does not encode a functional protein product. Pseudogenes usually arise from gene duplication or retrotransposition events and typically lack the regulatory elements or intact coding sequence necessary for gene expression. CSRP2P2 has no established role in human disease or normal physiology and is not considered to be a therapeutic target[5]. The functional gene, CSRP2 (Cysteine and glycine-rich protein 2), encodes a LIM domain protein involved in cytoskeletal regulation and has been studied for its tumor suppressor roles in some cancer types[1][3][4][6]. However, CSRP2P2 is a non-functional pseudogene related to CSRP2, and should not be confused with the active CSRP2 gene or its protein product[2][5].
None; no known mechanisms as the pseudogene is not functional
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CSRP2 pseudogene 2 (CSRP2P2).